JCV) Seroprevalence Among Zambian Adults Presenting with “Meningoencephalitis” to the University Teaching Hospital, Lusaka, Zambia
Medical Journal of Zambia, Vol. 46 (4): 277 - 285 (2019) Original Article A Study of the John Cunningham Virus (JCV) Seroprevalence among Zambian Adults presenting with “Meningoencephalitis” to the University Teaching Hospital, Lusaka, Zambia 1A. Patel, 2S. Lakhi, 1, 3 O. Siddiqi, 4I. Koralnik 1 University of Zambia, School of medicine, Department of Internal Medicine, Lusaka, Zambia 2 University Teaching Hospital, Department of Internal Medicine, Lusaka, Zambia 3 Department of Neurology, Beth Israel Deaconess Medical Centre, Boston, USA 4 Department of Neurological Sciences, Rush University Medical Centre, Chicago, USA ABSTRACT Results: Final analysis for JCV seroprevalence was done in 96 patients and noted to be 46% (95% CI, Background: The John Cunningham virus (JCV) is 35.62 – 56.31). The JCV seroprevalence in the HIV an opportunistic virus which leads to the positive group was 40.82% and in the HIV negative development of progressive multifocal group was 51.06 % but there was no statistical leukoencephalopathy (PML), which is a lytic difference (p-value 0.31). None of the other factors infection of oligodendrocytes of the central nervous studied had any impact on the JCV seroprevalence system in immunosuppressed patients. Infection such as age, gender, clinical presentation, CD4 with the JCV occurs in childhood and the virus count and co-morbid TB meningitis (TBM) remains quiescent in the body, activating during diagnosis. There was a bimodal distribution of age immunosuppression. Exposure to the virus can be associated with JCV seropositivity; with one peak detected by testing for JC virus specific antibodies in occurring in the 18 to 20 years age group and the an ELISA test.
[Show full text]